Chemicals - Specialty
Compare Stocks
4 / 10Stock Comparison
SOLS vs EMN vs HUN vs LIN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals
Chemicals - Specialty
SOLS vs EMN vs HUN vs LIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals | Chemicals - Specialty |
| Market Cap | $13.87B | $8.49B | $2.50B | $233.49B |
| Revenue (TTM) | $3.89B | $8.64B | $5.69B | $34.66B |
| Net Income (TTM) | $207M | $399M | $-324M | $7.13B |
| Gross Margin | 32.2% | 19.8% | 12.9% | 46.0% |
| Operating Margin | 18.8% | 9.4% | -1.0% | 28.8% |
| Forward P/E | 32.3x | 11.7x | — | 28.2x |
| Total Debt | $2.43B | $5.08B | $2.73B | $26.99B |
| Cash & Equiv. | $534M | $566M | $429M | $5.06B |
SOLS vs EMN vs HUN vs LIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Eastman Chemical Co… (EMN) | 100 | 109.1 | +9.1% |
| Huntsman Corporation (HUN) | 100 | 79.2 | -20.8% |
| Linde plc (LIN) | 100 | 249.0 | +149.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SOLS vs EMN vs HUN vs LIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SOLS is the #2 pick in this set and the best alternative if growth and momentum is your priority.
- 3.1% NII/revenue growth vs EMN's -6.7%
- +80.5% vs EMN's -6.3%
EMN is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 12 yrs, beta 1.32, yield 4.4%
- Beta 1.32, yield 4.4%, current ratio 1.37x
- Better valuation composite
HUN is the clearest fit if your priority is dividends.
- 5.9% yield, vs EMN's 4.4%, (1 stock pays no dividend)
LIN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
- 381.6% 10Y total return vs SOLS's 80.5%
- Lower volatility, beta 0.23, Low D/E 67.9%, current ratio 0.88x
- PEG 1.11 vs EMN's 3.65
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.1% NII/revenue growth vs EMN's -6.7% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.6% margin vs HUN's -5.7% | |
| Stability / Safety | Beta 0.23 vs HUN's 1.82, lower leverage | |
| Dividends | 5.9% yield, vs EMN's 4.4%, (1 stock pays no dividend) | |
| Momentum (1Y) | +80.5% vs EMN's -6.3% | |
| Efficiency (ROA) | 8.3% ROA vs HUN's -4.6%, ROIC 11.3% vs -0.6% |
SOLS vs EMN vs HUN vs LIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SOLS vs EMN vs HUN vs LIN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LIN leads in 2 of 6 categories
SOLS leads 1 • EMN leads 0 • HUN leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 8.9x SOLS's $3.9B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to HUN's -5.7%. On growth, LIN holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $3.9B | $8.6B | $5.7B | $34.7B |
| EBITDAEarnings before interest/tax | $907M | $1.2B | $160M | $12.1B |
| Net IncomeAfter-tax profit | $207M | $399M | -$324M | $7.1B |
| Free Cash FlowCash after capex | $79M | $498M | $135M | $5.1B |
| Gross MarginGross profit ÷ Revenue | +32.2% | +19.8% | +12.9% | +46.0% |
| Operating MarginEBIT ÷ Revenue | +18.8% | +9.4% | -1.0% | +28.8% |
| Net MarginNet income ÷ Revenue | +6.1% | +4.6% | -5.7% | +20.6% |
| FCF MarginFCF ÷ Revenue | — | +5.8% | +2.4% | +14.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -4.9% | +0.7% | +8.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -27.4% | -40.8% | -3.3% | +13.4% |
Valuation Metrics
Evenly matched — EMN and HUN each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 18.1x trailing earnings, EMN trades at a 69% valuation discount to SOLS's 58.6x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.36x vs EMN's 5.63x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $13.9B | $8.5B | $2.5B | $233.5B |
| Enterprise ValueMkt cap + debt − cash | $15.8B | $13.0B | $4.8B | $255.4B |
| Trailing P/EPrice ÷ TTM EPS | 58.60x | 18.11x | -9.04x | 34.54x |
| Forward P/EPrice ÷ next-FY EPS est. | 32.33x | 11.72x | — | 28.16x |
| PEG RatioP/E ÷ EPS growth rate | — | 5.63x | — | 1.36x |
| EV / EBITDAEnterprise value multiple | 16.53x | 9.00x | 19.38x | 20.12x |
| Price / SalesMarket cap ÷ Revenue | 3.57x | 0.97x | 0.44x | 6.87x |
| Price / BookPrice ÷ Book value/share | 10.08x | 1.42x | 0.84x | 5.94x |
| Price / FCFMarket cap ÷ FCF | — | 20.02x | 21.57x | 45.88x |
Profitability & Efficiency
LIN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-8 for HUN. LIN carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to SOLS's 1.76x. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs SOLS's 1/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.5% | +6.7% | -8.1% | +17.8% |
| ROA (TTM)Return on assets | +3.8% | +2.6% | -4.6% | +8.3% |
| ROICReturn on invested capital | +14.8% | +6.7% | -0.6% | +11.3% |
| ROCEReturn on capital employed | +18.6% | +7.5% | -0.7% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 5 | 2 | 6 |
| Debt / EquityFinancial leverage | 1.76x | 0.84x | 0.92x | 0.68x |
| Net DebtTotal debt minus cash | $1.9B | $4.5B | $2.3B | $21.9B |
| Cash & Equiv.Liquid assets | $534M | $566M | $429M | $5.1B |
| Total DebtShort + long-term debt | $2.4B | $5.1B | $2.7B | $27.0B |
| Interest CoverageEBIT ÷ Interest expense | 12.50x | 2.22x | -1.08x | 34.52x |
Total Returns (Dividends Reinvested)
SOLS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SOLS five years ago would be worth $18,055 today (with dividends reinvested), compared to $6,328 for HUN. Over the past 12 months, SOLS leads with a +80.5% total return vs EMN's -6.3%. The 3-year compound annual growth rate (CAGR) favors SOLS at 21.8% vs HUN's -12.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +77.3% | +16.7% | +42.0% | +17.8% |
| 1-Year ReturnPast 12 months | +80.5% | -6.3% | +16.4% | +12.2% |
| 3-Year ReturnCumulative with dividends | +80.5% | +6.8% | -32.1% | +40.6% |
| 5-Year ReturnCumulative with dividends | +80.5% | -28.0% | -36.7% | +80.3% |
| 10-Year ReturnCumulative with dividends | +80.5% | +36.1% | +54.8% | +381.6% |
| CAGR (3Y)Annualised 3-year return | +21.8% | +2.2% | -12.1% | +12.0% |
Risk & Volatility
Evenly matched — SOLS and LIN each lead in 1 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than HUN's 1.82 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SOLS currently trades 99.9% from its 52-week high vs EMN's 88.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.43x | 1.32x | 1.82x | 0.23x |
| 52-Week HighHighest price in past year | $87.41 | $84.18 | $15.89 | $521.28 |
| 52-Week LowLowest price in past year | $40.43 | $56.11 | $7.30 | $387.78 |
| % of 52W HighCurrent price vs 52-week peak | +99.9% | +88.2% | +90.5% | +96.7% |
| RSI (14)Momentum oscillator 0–100 | 60.2 | 53.1 | 60.8 | 53.7 |
| Avg Volume (50D)Average daily shares traded | 2.3M | 1.4M | 6.0M | 2.2M |
Analyst Outlook
Evenly matched — EMN and HUN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SOLS as "Buy", EMN as "Buy", HUN as "Hold", LIN as "Buy". Consensus price targets imply 11.0% upside for LIN (target: $559) vs -14.8% for HUN (target: $12). For income investors, HUN offers the higher dividend yield at 5.88% vs LIN's 1.19%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $75.17 | $79.89 | $12.25 | $559.14 |
| # AnalystsCovering analysts | 4 | 35 | 33 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +4.4% | +5.9% | +1.2% |
| Dividend StreakConsecutive years of raises | — | 12 | 0 | 6 |
| Dividend / ShareAnnual DPS | — | $3.30 | $0.85 | $6.00 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.2% | +0.1% | +2.0% |
LIN leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SOLS leads in 1 (Total Returns). 3 tied.
SOLS vs EMN vs HUN vs LIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SOLS or EMN or HUN or LIN a better buy right now?
For growth investors, Solstice Advanced Materials Inc.
(SOLS) is the stronger pick with 3. 1% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 1x trailing P/E (11. 7x forward), making it the more compelling value choice. Analysts rate Solstice Advanced Materials Inc. (SOLS) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SOLS or EMN or HUN or LIN?
On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.
1x versus Solstice Advanced Materials Inc. at 58. 6x. On forward P/E, Eastman Chemical Company is actually cheaper at 11. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Linde plc wins at 1. 11x versus Eastman Chemical Company's 3. 65x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — SOLS or EMN or HUN or LIN?
Over the past 5 years, Solstice Advanced Materials Inc.
(SOLS) delivered a total return of +80. 5%, compared to -36. 7% for Huntsman Corporation (HUN). Over 10 years, the gap is even starker: LIN returned +381. 6% versus EMN's +36. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SOLS or EMN or HUN or LIN?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
23β versus Huntsman Corporation's 1. 82β — meaning HUN is approximately 678% more volatile than LIN relative to the S&P 500. On balance sheet safety, Linde plc (LIN) carries a lower debt/equity ratio of 68% versus 176% for Solstice Advanced Materials Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SOLS or EMN or HUN or LIN?
By revenue growth (latest reported year), Solstice Advanced Materials Inc.
(SOLS) is pulling ahead at 3. 1% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Linde plc grew EPS 7. 1% year-over-year, compared to -46. 5% for Eastman Chemical Company. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SOLS or EMN or HUN or LIN?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus -4. 8% for Huntsman Corporation — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus -0. 7% for HUN. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SOLS or EMN or HUN or LIN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Linde plc (LIN) is the more undervalued stock at a PEG of 1. 11x versus Eastman Chemical Company's 3. 65x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Eastman Chemical Company (EMN) trades at 11. 7x forward P/E versus 32. 3x for Solstice Advanced Materials Inc. — 20. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LIN: 11. 0% to $559. 14.
08Which pays a better dividend — SOLS or EMN or HUN or LIN?
In this comparison, HUN (5.
9% yield), EMN (4. 4% yield), LIN (1. 2% yield) pay a dividend. SOLS does not pay a meaningful dividend and should not be held primarily for income.
09Is SOLS or EMN or HUN or LIN better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
23), 1. 2% yield, +381. 6% 10Y return). Both have compounded well over 10 years (LIN: +381. 6%, SOLS: +80. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SOLS and EMN and HUN and LIN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SOLS is a mid-cap quality compounder stock; EMN is a small-cap income-oriented stock; HUN is a small-cap income-oriented stock; LIN is a large-cap quality compounder stock. EMN, HUN, LIN pay a dividend while SOLS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.